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Introduction: Sepsis has been a factor of acute kidney injury (AKI); however, little is known about dialysis-requiring
AKI and the risk of severe sepsis after survival to discharge.
Methods: We conducted a population-based cohort study based on the Taiwan National Health Insurance
Research Database from 1999 to 2009. We identified patients with AKI requiring dialysis during hospitalization and
survived for at least 90 days after discharge, and matched them with those without AKI according to age, sex, and
concurrent diabetes. The primary outcome was severe sepsis, defined as sepsis with a diagnosis of acute organ
dysfunction. Individuals who recovered enough to survive without acute dialysis were further analyzed.
Results: We identified 2983 individuals (mean age, 62 years; median follow-up, 3.96 years) with dialysis-requiring
AKI and 11,932 matched controls. The incidence rate of severe sepsis was 6.84 and 2.32 per 100 person-years
among individuals with dialysis-requiring AKI and without AKI in the index hospitalization, respectively. Dialysis-
requiring AKI patients had a higher risk of developing de novo severe sepsis than the non-AKI group. In subgroup
analysis, even individuals with recovery from dialysis-requiring AKI were at high risk of developing severe sepsis.
Conclusions: AKI is an independent risk factor for severe sepsis. Even patients who recovered from AKI had a high
risk of long-term severe sepsis.Introduction
Sepsis can cause multiorgan dysfunction, especially of the
heart, lung and kidney, causing high morbidity and mortal-
ity in hospitalized patients [1]. Severe sepsis, defined as sepsis
with organ dysfunction, hypoperfusion or hypotension, oc-
curs in about 11% to 27% of ICU patients, with a mortality
rate of about 18% to 55% [2-4]. The incidence and severity
of sepsis has increased in recent years and has contributed
substantially to the disease burden over time [5].
AKI is a common complication, especially in critically ill
patients, occurring in 8% of hospitalized patients and in
approximately 50% of ICU patients [6]. Sepsis is the most
common cause of AKI. Severe sepsis, including septic
shock, accounts for almost half of all cases of AKI in the* Correspondence: d99849016@ntu.edu.tw; klchien@ntu.edu.tw
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reproduction in any medium, provided the orICU [7,8]. In humans, extrarenal organ dysfunction fre-
quently coexists with AKI, potentiating the already high
rates of AKI-associated morbidity and mortality. Unique
systemic inflammatory patterns have also been observed
for different mechanisms of AKI [9], as the deleterious
interaction arises, at least in part, from systemic inflam-
matory changes, activation of proapoptotic pathways, in-
creases in leukocyte trafficking and dysregulated channel
expression [10]. These in turn can lead to long-term sep-
sis. The aim of this study was to evaluate the incidence of
severe sepsis after hospitalization in patients with or
without AKI requiring dialysis in a large-scale, population-
based administration database in Taiwan. We hypothesized
that AKI might be an independent risk factor for develop-
ing severe sepsis, regardless of recovery of renal function
recovery.This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Data sources
The National Health Insurance (NHI) is a nationwide,
compulsory, comprehensive health system in Taiwan.
Patients were drawn from the NHI Research Database
(NHIRD), which was released for research purposes by
the National Health Research Institutes, Taipei, Taiwan
[11]. The NHIRD, one of the largest databases in the
world, covers nearly all (99%) inpatient and outpatient
claims for its population of more than 22 million people,
and it has been used extensively in previous studies
[5,12]. The NHIRD provides encrypted patient identifi-
cation numbers; age; sex; dates of hospital admission and
discharge; medical institutions providing services; Inter-
national Classification of Diseases, Ninth Edition, Clinical
Modification (ICD-9-CM), codes of diagnoses and proce-
dures; and outcome at hospital discharge (recovered, died
or transferred out).
Patient selection and definition
The NHIRD consists of all the original claim data and
registration files of one million individuals from 1999 to
2008. These one million individuals were randomly sam-
pled from the 2000 Registry for Beneficiaries of the Taiwan
NHI program and screening comorbidities by using the
medical records for one year preceding admission. We
linked to diagnostic codes through the hospitalization
claims data to identify all episodes of AKI and the corre-
sponding order codes used for the study subjects. WeFigure 1 Flow diaphragm of the study population. AKI: acute kidney indefined the first AKI hospitalization requiring dialysis as
the index hospitalization for each individual. Participants
who received dialysis during the index hospitalization
were included. We excluded individuals who had a previ-
ous diagnosis of AKI, had received a kidney transplant or
any form of dialysis preceding the index hospitalization
AKI (n = 6,420), were hospitalized for more than 180 days
with AKI (n = 36), died during the index hospitalization
AKI (n = 718) or withdrew from the NHI within three
months after discharge (n = 1,382). Each AKI patient was
then matched with four hospitalized patients without AKI
according to age, sex and history of diabetes (Figure 1). In-
formed consent was originally obtained by the NHRI, and,
since patients were anonymous in the present study, in-
formed consent was not required. Also, since the identifi-
cation numbers of all individuals in the NHRID were
encrypted to protect the privacy of the individuals, this
study was exempt from a full ethical review by the institu-
tional ethics review board of National Taiwan University
Hospital (reference no. 201212021RINC).
Ascertainment of study outcome
Patients were tracked for outcomes beginning 90 days
after discharge and ending at 31 December 2009. The
main study outcome was severe sepsis. The method of
identification of patients with severe sepsis was similar
to that used by Angus et al. [3], who selected all acute
care hospitalizations with ICD-9-CM codes for both a
bacterial or fungal infection process and a diagnosis ofjury.
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dysfunction as modified by Shen et al. [5] (listed in
Table 1). Sepsis was defined according to the American




Cardiovascular 458.0 Hypotension, postural
458.8 Hypotension, specified type, not
elsewhere classified
458.9 Hypotension, arterial, constitutional
785.5 Shock
785.51 Shock, cardiogenic
785.59 Shock, circulatory or septic
796.3 Hypotension, transient
Respiratory 518.81 Acute respiratory failure
518.82 Acute respiratory distress syndrome
(ARDS)






96.04 Endotracheal intubation (emergency
procedure)
93.9 Continuous positive airway pressure
Renal 580.x Acute glomerulonephritis
584.x Acute renal failure
586 Renal shutdown, renal failure unspecified
39.95 Hemodialysis
Hepatic 570 Acute hepatic failure or necrosis
572.2 Hepatic encephalopathy
573.3 Hepatitis (septic and not elsewhere
classified)
573.4 Hepatic infarction
Neurologic 293 Transient organic psychosis
348.1 Anoxic brain injury
348.3 Encephalopathy, acute
780.01 Coma
780.09 Altered consciousness, unspecified
89.14 Electroencephalography
Hematologic 286.2 Disseminated intravascular coagulation
286.6 Purpura fulminans
286.9 Coagulopathy
287.3-5 Thrombocytopenia, primary, secondary or
unspecified
790.92 Abnormal coagulation profile
Metabolic 276.2 Acidosis, metabolic or lacticMedicine (ACCP/SCCM) as systemic inflammatory syn-
drome in response to infection, which, when associated
with acute organ dysfunction, is said to be severe [2].
For patients with more than one hospital admission for
severe sepsis during the study period, the first episode of
sepsis was included.Statistical analyses
For individuals with and those without AKI and dialysis,
continuous variables were compared using an unpaired
t-test and are expressed as mean values with SD. Cat-
egorical variables were compared using a χ2 test and
expressed as a percentage. The person-years were calcu-
lated from enrollment to outcome, death or the end of
the study period. Incidence rates of severe sepsis were
calculated for participants with and those without AKI
and dialysis, respectively.
Each acute dialysis patient was matched with four
non-AKI individuals according to age, sex and history of
diabetes. Crude hazard ratios (HRs) with 95% confidence
intervals (CIs) were derived from Cox proportional haz-
ards models, and matched individuals without AKI or
dialysis constituted the reference group. A Kaplan–
Meier curve was generated from unadjusted hazards
models. We further adjusted for age, sex, comorbidities,
procedure codes and a propensity score in the multivari-
ate models. Subsequent advanced chronic kidney disease
(CKD) after discharge was evaluated for its effect on
long-term severe sepsis using a time-dependent Cox
analysis. The adjusted HR values for severe sepsis were
further stratified according to comorbidities.
We used a propensity score approach to account for
baseline differences between the AKI groups. Multiple lo-
gistic regressions were used to generate propensity scores,
which were the predicted probabilities of AKI requiring
dialysis. Covariates that were statistically significant in the
unadjusted analysis were fit into the model, including age;
ICU admission during the index hospitalization; admission
frequency; use of mechanical ventilation; comorbidities
before admission, such as diabetes mellitus, tumor with
metastasis, CKD, chronic obstructive pulmonary disease
and congestive heart failure; and comorbidities during
index hospitalization, such as those of renal, metabolic,
pulmonary or cardiovascular origin. We incorporated
this score into a Cox proportional hazards model as a
covariate.
In subgroup analysis, each acute dialysis patient with
recovery from dialysis was matched with patients with-
out AKI according to age, sex and history of diabetes. A
two-sided P value less than 0.05 was considered statisti-
cally significant. All data were analyzed using R statis-
tical software (version 2.14.1; Free Software Foundation,
Inc, Boston, MA, USA).
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A total of 2,983 individuals with AKI requiring dialysis
who survived at least 90 days after hospital discharge were
identified, and 11,932 individuals without dialysis or AKI
were matched. Baseline characteristics between individ-
uals with or without AKI acute dialysis are listed in
Table 2. The acute dialysis group had more macrovascular
and microvascular disease than the non-AKI group.Table 2 Baseline characteristics of study population stratified
Patient characteristics Non-AKI g
(N = 11,93
Mean age (years) 62.03 ± 14.
Males (%) 6,004 (50.3
Admission frequency 0.57 ± 1.61
Charlson Comorbidity Index score 1.67 ± 1.72
Comorbidities (before admission)
Myocardial infarction 122 (1%)
Congestive heart failure 426 (3.6%)
Peripheral vascular disease 161 (1.3%)
Cerebrovascular disease 1,117 (9.4%
Dementia 204 (1.7%)
COPD 1,854 (15.5
Rheumatologic disease 158 (1.3%)
Peptic ulcer 2,182 (18.3
Moderate or severe liver disease 1,288 (10.8
Diabetes mellitus 5,973 (50.1
Hemiplegia 147 (1.2%)
Chronic kidney disease 845 (7.1%)
Solid tumor 657 (5.5%)
Tumor with metastasis 198 (1.7%)









Upper GI 72 (0.6%)
Lower GI 128 (1.1%)
Hepatobiliary 197 (1.7%)
ICU admission during index hospitalization 898 (7.5%)
Mechanical ventilation 376 (3.2%)
Mortality 2603 (21.8%
Severe sepsis 1,250 (10.5
aAKI: acute kidney injury; COPD: chronic obstructive pulmonary disease; GI: gastroinAmong the 2,983 individuals with AKI requiring dialysis,
2,265 patients remained on dialysis and 718 recovered
from AKI requiring dialysis after 90 days postdischarge.
The mean age of the enrolled participants was 62 ±
14.8 years, and 50.3% were men. Compared with non-
AKI participants, those with acute dialysis had a higher
mean Charlson Comorbidity Index score (3.7 ± 2.2 vs.
1.7 ± 1.7) and more comorbidities before the indexby acute kidney injurya
roup AKI group P-value
2) (N = 2,983)
84 62.03 ± 14.84 0.995
%) 1,501 (50.3%) 0.999
2.28 ± 2.75 <0.001




) 477 (16%) <0.001
87 (2.9%) <0.001
%) 497 (16.7%) 0.137
55 (1.8%) 0.038
%) 786 (26.3%) <0.001
%) 285 (9.6%) 0.049

















) 1,386 (46.5%) <0.001
%) 675 (22.6%) <0.001
testinal.
Figure 2 Kaplan–Meier curve for incidence of severe sepsis
after discharge for patients with or without acute kidney injury.
AKI: acute kidney injury.
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cular and cerebrovascular disease. Participants with
acute dialysis had a much higher prevalence of under-
lying CKD (75.4% vs. 7.1%) than did non-AKI patients.
During their hospitalization, patients with acute dialysis
were more likely to receive mechanical ventilation (17.7
vs. 3.2%; P < 0.001), had higher long-term mortality (46.5
vs. 21.8%; P < 0.001) and developed severe sepsis more
often (22.6 vs. 10.5%) than did patients without AKI.
The respective rates for severe sepsis were 22.6% and
10.5%.
After a median follow-up period of 3.96 years, the inci-
dence rates of severe sepsis were 6.84 and 2.32 per 100
person-years among individuals with and those without
AKI and dialysis in the index hospitalization, respect-
ively, resulting in a HR of 2.87 (95% CI, 2.62 to 3.16; P <
0.001). The propensity score–adjusted HR was 1.83 (95%
CI, 1.57 to 2.13; P < 0.001). After multivariable adjust-
ment, patients with AKI requiring dialysis were at a
higher risk than patients in the non-AKI group for de-
veloping de novo severe sepsis (HR: 1.99 (95% CI: 1.71 to
2.31); P < 0.001) (Table 3). This model had good validity
with a C-index concordance statistic of 0.79 and an ad-
justed generalized R2 of 0.12. The Cox proportional haz-
ards model is plotted in Figure 2. In time-dependent
analysis, the AKI group requiring dialysis had a higher
risk of developing severe sepsis than the non-AKI group
in the first year and decreased gradually with time (one-
year HR: 3.44 (95% CI: 2.59 to 4.56), two-year HR: 2.26
(95% CI: 1.83 to 2.78] and three-year HR: 2.05 (95% CI:
1.70 to 2.48), respectively) (Table 4). For participantsTable 3 Crude and adjusted hazard ratios of severe sepsis
for acute kidney injury statusa
Analysis
model
AKI vs. non-AKI Recovery vs. non-AKI
HR (95% CI) P-value HR (95% CI) P-value
Univariate 2.87 (2.62 to 3.16) <0.001 2.80 (2.34 to 3.34) <0.001
Multivariate
Model 1 1.83 (1.57-2.13) <0.001 1.48 (1.06 to 2.06) 0.02
Model 2 1.99 (1.71 to 2.31) <0.001
Model 3 1.58 (1.15 to 2.16) <0.001
Model 4 1.95 (1.67 to 2.28) <0.001
aAKI: acute kidney injury; HR: hazard ratio. Model 1: Adjusted for age, sex and
propensity score.
Model 2: Adjusted for age, sex, propensity score, ICU admission, admission
frequency, Charlson Comorbidity Index score, comorbidities before index
hospitalization (cerebrovascular disease, dementia, chronic obstructive
pulmonary disease, hemiplegia and metastatic tumor) and respiratory and
hematologic comorbidities during index hospitalization. Model 3: Adjusted for
age, sex, propensity score, admission frequency, Charlson Comorbidity Index
score, comorbidities before index hospitalization (peptic ulcer and diabetes
mellitus) and cardiovascular and respiratory comorbidities during index
hospitalization. Model 4: Model 2 adjusted with subsequent advanced CKD
after hospital discharge as a time-varying covariate. Advanced CKD is defined
as patients with serum creatinine levels above 6 mg/dl and a concomitant
erythropoiesis-stimulating agent prescription.with and those without recovery from AKI and dialysis,
the tendency for the development of severe sepsis did a
95% CI of 0.9 to 1.34 (P = 0.457). The increased risk of de-
veloping long-term severe sepsis following hospitalization
complicated by AKI requiring dialysis was consistent
across patient subgroups, including cerebrovascular dis-
ease, chronic obstructive pulmonary disease, hemiplegia
and diabetes mellitus (Figure 3).
In a subgroup analysis, we compared individuals who
recovered from AKI requiring dialysis with non-AKI in-
dividuals. The crude HR and propensity score–adjusted
HRs were 2.80 (95% CI: 2.34 to 3.34; P < 0.001) and 1.48
(95% CI: 1.06 to 2.06; P = 0.02), respectively. The recov-
ery group was at a higher risk for severe sepsis than the
non-AKI group after multivariable adjustment for the
covariates listed in Table 3 (HR: 1.58 (95% CI: 1.15 to
2.16); P < 0.001). This model also showed good validity,
with a C-index concordance statistic of 0.78 and an ad-
justed generalized R2 of 0.15.Discussion
AKI is an independent predictor of increasing mortality
in critically ill patients [13,14]. Our study demonstrates
that AKI requiring dialysis is associated with subsequent
long-term severe sepsis. After a median follow-up of
3.96 years, the incidence of severe sepsis in the AKI
group was about threefold the incidence of severe sepsis
in the non-AKI group. In a subgroup analysis, we found
that, even in individuals who recovered from AKI and
dialysis, the incidence of severe sepsis was 58% higher
than that in individuals without AKI, suggesting that
Table 4 Time-dependent analysis of the risk of
developing severe sepsisa
Model AKI vs. non-AKI Recovery vs. non-AKI
HR (95% CI) P-value HR (95% CI) P-value
Model 5 3.44 (2.59 to 4.56) <0.001 1.61 (1.00 to 2.59) 0.049
(one year of
follow-up)
Model 6 2.26 (1.83 to 2.78) <0.001 1.61 (1.09 to 2.37) 0.017
(two years of
follow-up)
Model 7 2.05 (1.70 to 2.48) <0.001 1.68 (1.18 to 2.40) 0.004
(three years of
follow-up)
aAKI: acute kidney injury. (a) AKI group vs. non-AKI group. (b) Recovery group
vs. non-AKI group). Model 5a: Adjusted for age, propensity score, admission
frequency, comorbidities before index hospitalization (chronic kidney disease
(CKD), cerebrovascular disease, dementia, chronic pulmonary disease and
metastatic tumor), hematologic comorbidities during index hospitalization and
advanced CKD. Advanced CKD is defined as patients with serum creatinine
levels above 6 mg/dl and a concomitant erythropoiesis-stimulating agent
prescription. Model 5b: Adjusted for age, propensity score, admission
frequency, Charlson Comorbidity Index score, comorbidities before index
hospitalization (cerebrovascular disease and peptic ulcer) and cardiovascular
and respiratory comorbidities during index hospitalization. Model 6a: Adjusted
for age, propensity score, Charlson Comorbidity Index score, admission
frequency, comorbidities before index hospitalization (CKD, cerebrovascular
disease, dementia and chronic obstructive pulmonary disease), metabolic and
respiratory comorbidities during index hospitalization and advanced CKD.
Model 6b: Adjusted for age, propensity score, admission frequency, Charlson
Comorbidity Index score, comorbidities before index hospitalization
(cerebrovascular disease and peptic ulcer) and cardiovascular, respiratory and
hepatic comorbidities during index hospitalization. Model 7a: Adjusted for age,
propensity score, Charlson Comorbidity Index score, admission frequency,
comorbidities before index hospitalization (CKD, cerebrovascular disease,
dementia and chronic obstructive pulmonary disease) and metabolic,
hematologic and respiratory comorbidities during index hospitalization. Model
7b: Adjusted for age, propensity score, admission frequency, Charlson
Comorbidity Index score, comorbidities before index hospitalization
(cerebrovascular disease and peptic ulcer) and respiratory comorbidities
during index hospitalization.
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severe sepsis, regardless of recovery from AKI. The
prevalence rate of severe sepsis was 2.32 per 100 person-
years in the non-AKI group, which is consistent with the
national estimate of 2.26 per 100 person-years in hos-
pital patients in the United States [3].
The prevalence of sepsis after AKI has been under-
estimated, and, until now, only a few studies have em-
phasized the effect of AKI on the incidence of sepsis. For
example, a cohort study of contrast-induced AKI illus-
trated that 45% of patients developed sepsis subsequently
during hospitalization, but the long-term development of
sepsis was not reported [15]. Another study retrospectively
investigated the incidence of infection in critically ill pa-
tients with AKI and found that 80% of critical ill patients
with AKI developed infections during hospitalization [16].
Of all episodes of infection, 46.2% occurred before, 40.3%
during and 13.4% after discontinuation of renal replace-
ment therapy. Single-center enrollment or a small sample
size limits the robustness of studies, however, and thedefinition of sepsis is often overestimated. Recently, in a
multicenter, observational study, Mehta et al. analyzed
data from 618 critically ill patients in the ICU and exam-
ined the relationship between sepsis and AKI [17]. The
mortality rate for patients with who developed sepsis after
AKI was higher than that for sepsis-free patients (44% vs.
21%; P < 0.001) and similar to that for patients with sepsis
preceding AKI (48% vs. 44%; P = 0.41). By using compre-
hensive administrative data in Taiwan in our present
study, we have provided strong evidence that AKI is an in-
dependent risk factor for developing severe sepsis, even
when it occurs a long time after index hospitalization. Fur-
thermore, although dialysis was an important predictor of
sepsis after AKI diagnosis, our results show that patients
who recovered from dialysis still had a higher risk of sub-
sequent severe sepsis, suggesting that chronic dialysis itself
is not the crucial source of post-AKI sepsis in these
patients.
Patients in the ICU are dying as a result of AKI, but
not simply from AKI. Experimental and small observa-
tional studies have shown that AKI negatively affects im-
munity and is associated with higher rates of infection
[18]. AKI patients frequently develop a vicious cycle of
immune dysfunction, sepsis and multiorgan failure. In-
deed, severe sepsis is currently the major cause of AKI
in the United States [19]. The host response to sepsis in-
volves an inflammatory response which activates innate
immunity. If this persists, the immune response will lead
to a release of a multitude of proinflammatory products,
which frequently cause organ dysfunction, including kid-
ney failure [20-26]. Our finding that patients with AKI
were fragile and were more likely to develop severe sep-
sis reinforces the fact that acute renal dysfunction plays
a crucial immunomodulatory role in individuals in
stressed states. Also, AKI has been proved to facilitate
organ cross-talk in the heart, brain, lungs, liver and
other organs via the relevant biological pathways [27,28].
Multiple end-stage organ injury after AKI may worsen
the severity of infection in severe sepsis.
Though renal function has been thought to be revers-
ible after AKI, recent studies have provided evidence
that AKI increases the risk of CKD and end-stage renal
disease requiring dialysis [7,29,30]. A systematic review
and meta-analysis showed a higher risk of CKD and
chronic dialysis in patients after AKI [31]. Clinical stud-
ies have also demonstrated that CKD attenuated immun-
ity and subsequently increased the risk of pneumonia,
influenza and associated sepsis [32]. Thus, increased risk
of severe sepsis, even among the recovery group, with
subsequent CKD and impaired immunity is reasonable.
In our analysis, we further adjusted for advanced CKD
status represented by erythropoietin use, and we found
that the AKI group requiring dialysis was still at a higher
risk for developing severe sepsis (HR: 1.95 (95% CI: 1.67
Figure 3 Risk of severe sepsis associated with acute kidney injury at index hospitalization by participant characteristics. AKI: acute
kidney injury.
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still at risk of developing severe sepsis after removal of
the uremia effect.
Our study has several limitations. First, when using ad-
ministrative databases, the diagnosis of AKI, severe sep-
sis and other comorbidities are totally based on ICD and
procedure codes, so misclassification inevitably occurs.
However, the misclassification is often nondifferential
and the outcome difference is toward null. In a recent
validation study, a diagnostic code for AKI plus a pro-
cedure code for dialysis had a sensitivity and specificity
of more than 90% for capturing patients with AKI re-
quiring dialysis [33]. Furthermore, the NHIB in Taiwan
has randomly reviewed medical charts and audited all
medical charges [34]; hence, the data quality is trust-
worthy. Second, individual information such as smoking,
drinking and site of infection was not available through
administrative data in the NHIRD. We were also unable
to obtain detailed laboratory data, such as serum cre-
atinine level or urinary protein excretion. There may be
residual confounding factors caused by these unknown
data. However, these factors have less effect on our out-
come than the factors we adjusted for, and the robust-
ness of the association between AKI and long-term
severe sepsis is largely unaffected.
Conclusions
In this study, we have demonstrated that AKI is an inde-
pendent risk factor for the development of long-term se-
vere sepsis. The incidence of severe sepsis is threefold in
patients with AKI requiring dialysis compared with non-AKI patients. Our study further indicates that individ-
uals who recovered from AKI and dialysis still had a
higher risk than non-AKI patients of developing severe
sepsis. Therefore, all AKI patients requiring dialysis, re-
gardless they recover, should be considered at risk for
severe sepsis and should be aggressively managed for in-
fection prevention. Because of the high mortality in se-
vere sepsis, awareness of the high risk of severe sepsis
after AKI should be raised in outpatient clinical practice.
Key messages
 Sepsis has been a factor in patients with AKI; however,
the long-term risk of severe sepsis in patients after AKI
requiring dialysis may be overlooked.
 We have revealed that AKI is an independent risk
factor for the development of long-term severe
sepsis. The incidence of severe sepsis in the AKI
group was about threefold the incidence of severe
sepsis in the non-AKI group after a median of four
years follow-up.
 We also revealed that even patients who recovered
from AKI had a high risk of long-term severe sepsis.
Therefore, we should view AKI as not only a self-
limiting acute disease but also a long-lasting
immunomodulatory disorder.
 We need to raise the awareness of the high risk of
severe sepsis after AKI in outpatient clinical
practice. All AKI patients requiring dialysis,
regardless of whether they recover, should be
aggressively managed for infection prevention.
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